Generic Substitution Noninterference Act
Sponsored By: Representative Maloney, Carolyn B. [D-NY-12]
Unknown
Summary
Generic Substitution Noninterference Act This bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Maloney, Carolyn B. [D-NY-12]
NY • D
Cosponsors
Rep. Cicilline, David N. [D-RI-1]
RI • D
Sponsored 4/7/2022
Rep. Nadler, Jerrold [D-NY-12]
NY • D
Sponsored 4/7/2022
Sen. Welch, Peter [D-VT]
VT • D
Sponsored 4/7/2022
Rep. Schakowsky, Janice D. [D-IL-9]
IL • D
Sponsored 4/7/2022
Rep. Porter, Katie [D-CA-47]
CA • D
Sponsored 4/7/2022
Rep. DeSaulnier, Mark [D-CA-10]
CA • D
Sponsored 4/7/2022
Rep. Raskin, Jamie [D-MD-8]
MD • D
Sponsored 4/7/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov